News
The Georgia Bureau of Investigation reported that the shooter had expressed discontent with the COVID-19 vaccine and wanted ...
The owner of the United States' largest pharmacy benefit manager (PBM) is declining to cover Gilead Sciences’ long-acting HIV ...
Gov. Ned Lamont signed Public Act 25-167 into law July 30. Its aim is to implement the task force’s recommendations in an effort to reduce the cost of prescription drugs for individuals and the state ...
Executives at Gilead Sciences, the biotech behind a long list of HIV treatments and preventative medicines, have spoken with ...
CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...
CVS Health will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, despite the medicine's proven effectiveness ...
Is August too early to get this year’s influenza vaccine? Here’s when and where flu shots are available and when the CDC recommends getting one.
22h
Investor's Business Daily on MSNCVS Health Stock Runs Hot Once Again, Hitting A New Buy Point
CVS Health stock offers an above-average dividend yield for investors seeking income and it's run up to a new buy point.
On Tuesday, Federal Court Judge Mitchell Goldberg issued a ruling that is the second staggering decision against Woonsocket-based CVS in recent weeks. Whistleblowers brought the two cases alleging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results